Clinical Trial Update: Public Access Defibrillation (PAD) Community Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial on public access defibrillation (PAD) in community settings has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Cardiac Arrest
• Heart Disease
• Myocardial Infarction
• Sudden Cardiac Death
• Ventricular Fibrillation

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Arrhythmia, Heart Arrest | Phase 3 | Status: COMPLETED